Key facts
- This page summarizes Ravi Savarirayan's Form 3 filing for Immuron Ltd (IMRN).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 29 Apr 2026, 16:00.
Key filing fact
Ownership activity is grounded in SEC Form 3 disclosures.
Shares, units, or other non-derivative securities reported in this filing.
No transaction description listed
No transaction description listed
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
No transaction description listed
No transaction description listed
Additional SEC filing notes
Footnote F1
The option became exercisable as to 333,333 shares on December 8, 2025, and becomes exercisable as to the remaining 333,333 shares on December 8, 2026, and 333,334 shares on December 8, 2027.
Footnote F2
The option will become exercisable as to 333,333 shares on November 26, 2026; 333,333 shares on November 24, 2027, and 333,334 shares on November 24, 2028.
Footnote F3
The exercise price of this option, originally denominated in Australian dollar ("AUD") in the amount of AUD $0.145 is presented in the table in U.S.dollars ("USD") based on the exchange rate reported by the Reserve Bank of Australia on April 28, 2026, which was AUD 1.00 = USD 0.7172.
Footnote F4
The exercise price of this option, originally denominated in Australian dollar ("AUD") in the amount of AUD $0.110 is presented in the table in U.S.dollars ("USD") based on the exchange rate reported by the Reserve Bank of Australia on April 28, 2026, which was AUD 1.00 = USD 0.7172.